Literature DB >> 11826735

Peripheral analgesic and antiinflammatory effects of opioids.

C Stein1, H Machelska, M Schäfer.   

Abstract

Traditionally, opioids were considered the prototype of centrally acting analgesics. In the past decade a substantial literature has emerged demonstrating that opioids can produce potent and clinically measurable analgesia by activation of opioid receptors on peripheral terminals of primary sensory neurons. In addition, endogenous ligands of these peripheral receptors were discovered in immune cells. Major recent findings in peripheral opioid analgesia include the relative lack of tolerance under inflammatory conditions, tetrapeptides as novel peripherally restricted compounds, the potent antiinflammatory activity of mu- and kappa-agonists and the identification of selectins as important molecules governing the homing of opioid cells to injured tissue. In addition to the extensively documented efficacy of locally applied morphine in post-surgical pain, clinical studies have now moved into the field of chronic arthritic pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11826735     DOI: 10.1007/s003930170004

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  14 in total

1.  A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesia.

Authors:  Anne E Olesen; Richard Upton; David J R Foster; Camilla Staahl; Lona L Christrup; Lars Arendt-Nielsen; Asbjørn M Drewes
Journal:  Clin Pharmacokinet       Date:  2010-12       Impact factor: 6.447

Review 2.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

Review 3.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

4.  Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.

Authors:  Daniel J Bruce; Cristina D Peterson; Kelley F Kitto; Eyup Akgün; Sophia Lazzaroni; Phillip S Portoghese; Carolyn A Fairbanks; George L Wilcox
Journal:  Anesthesiology       Date:  2019-09       Impact factor: 7.892

5.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

6.  Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site.

Authors:  Josephine L Martin; Lisa Koodie; Anitha G Krishnan; Richard Charboneau; Roderick A Barke; Sabita Roy
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

7.  Intradermal mesotherapy versus intravenous dexketoprofen for the treatment of migraine headache without aura: a randomized controlled trial.

Authors:  Ilker Akbas; Meryem Betos Kocak; Abdullah Osman Kocak; Sultan Tuna Akgol Gur; Sinem Dogruyol; Mehmet Demir; Zeynep Cakir
Journal:  Ann Saudi Med       Date:  2021-06-01       Impact factor: 1.526

8.  The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway.

Authors:  Irina Vetter; Bruce D Wyse; Gregory R Monteith; Sarah J Roberts-Thomson; Peter J Cabot
Journal:  Mol Pain       Date:  2006-07-16       Impact factor: 3.395

Review 9.  The use of lipid-based nanocarriers for targeted pain therapies.

Authors:  Susan Hua; Sherry Y Wu
Journal:  Front Pharmacol       Date:  2013-11-21       Impact factor: 5.810

Review 10.  Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2013-10-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.